Stock Earnings

Question 1

Quels sont les états financiers clés de Esperion Therapeutics Inc ?

Accepted Answer

Selon le dernier état financier (Form-10K), Esperion Therapeutics Inc a un total d'actifs de $343, un bénéfice net loss de $-51

Question 2

Quels sont les ratios financiers clés pour ESPR ?

Accepted Answer

Le ratio de liquidité de Esperion Therapeutics Inc est 0.46, la marge nette est -15.36, les ventes par action sont de $1.77.

Question 3

Comment les revenus de Esperion Therapeutics Inc sont-ils répartis par segment ou géographie ?

Accepted Answer

Esperion Therapeutics Inc largest revenue segment is Pharmaceutical, at a revenue of 332,314,000 in the most earnings release.For geography, United States is the primary market for Esperion Therapeutics Inc, at a revenue of 332,314,000.

Question 4

Esperion Therapeutics Inc est-elle rentable ?

Accepted Answer

no, selon les derniers états financiers, Esperion Therapeutics Inc a un bénéfice net loss de $-51

Question 5

Esperion Therapeutics Inc a-t-elle des passifs ?

Accepted Answer

yes, Esperion Therapeutics Inc a un passif de 732

Question 6

Combien d'actions en circulation Esperion Therapeutics Inc a-t-elle ?

Accepted Answer

Esperion Therapeutics Inc a un total d'actions en circulation de 195.85

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	303	332	116	75	78	227
Revenue Growth (YoY)	3%	186%	55%	-4%	-66%	53%
Cost of Revenue	127	68	43	27	14	2
Gross Profit	176	263	73	48	64	225
Selling, General & Admin	161	163	142	109	171	199
Research & Development	44	46	86	118	106	146
Operating Expenses	206	209	228	228	277	346
Other Non Operating Income (Expenses)	0	0	0	0	3	0
Pretax Income	-105	-51	-209	-233	-269	-143
Income Tax Expense	0	--	--	--	--	--
Net Income	-105	-51	-209	-233	-269	-143
Net Income Growth	22%	-76%	-10%	-13%	88%	47%
Shares Outstanding (Diluted)	200.73	187.18	103.1	66.4	28.9	27.5
Shares Change (YoY)	3%	82%	55%	130%	5%	1%
EPS (Diluted)	-0.53	-0.27	-2.02	-3.52	-9.31	-5.23
EPS Growth	22%	-86%	-42%	-62%	78%	46%
Free Cash Flow	-93	-23	-135	-174	-263	-98
Free Cash Flow Per Share	-0.46	-0.12	-1.3	-2.62	-9.1	-3.56
Gross Margin	58.08%	79.21%	62.93%	64%	82.05%	99.11%
Operating Margin	-9.57%	16.26%	-133.62%	-238.66%	-273.07%	-53.3%
Profit Margin	-34.65%	-15.36%	-180.17%	-310.66%	-344.87%	-62.99%
Free Cash Flow Margin	-30.69%	-6.92%	-116.37%	-231.99%	-337.17%	-43.17%
EBITDA	-29	54	-155	-179	-213	-121
EBITDA Margin	-9.57%	16.26%	-133.62%	-238.66%	-273.07%	-53.3%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-29	54	-155	-179	-213	-121
EBIT Margin	-9.57%	16.26%	-133.62%	-238.66%	-273.07%	-53.3%
Effective Tax Rate	0%	--	--	--	--	--

Esperion Therapeutics Inc (ESPR) Price

ESPR Stock Price Chart

ESPR Income

Follow-Up Questions